Clinical Trials to Assess the Efficacy and Safety of HLIM

Clinical trial NCT03827590 · UNKNOWN

Trial details

NCT number: NCT03827590
Sponsor: SamA Pharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Upper Respiratory Tract Infection Acute Bronchitis

Start date: 2018-11-29
Primary completion: 2019-05-30
Enrollment: 487

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.